Kanawha Capital Management LLC / ABT
Kanawha Capital Management LLC’s Abbott Laboratories Position
Does Kanawha Capital Management LLC own Abbott Laboratories (ABT)? Yes — 182.3K shares worth $19M (+1.32% of its 13F portfolio) as of Q1 2026, up from 179.4K shares the prior filed quarter.
Position Value
$19M
Q1 2026
Shares
182.3K
% of Portfolio
+1.32%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 182.3K | $19M | +1.32% |
| Q4 2025 | 179.4K | $22M | +1.55% |
| Q3 2025 | 176.3K | $24M | +1.63% |
| Q2 2025 | 177.4K | $24M | +1.79% |
| Q1 2025 | 177.8K | $24M | +1.83% |
| Q4 2024 | 177.6K | $20M | +1.58% |
| Q3 2024 | 177.5K | $20M | +1.47% |
| Q2 2024 | 186.2K | $19M | +1.51% |
| Q1 2024 | 177.8K | $20M | +1.61% |
| Q4 2023 | 174.7K | $19M | +1.76% |
| Q3 2023 | 182.8K | $18M | +1.71% |
| Q2 2023 | 182.2K | $20M | +1.83% |
| Q1 2023 | 181.7K | $18M | +1.76% |
| Q4 2022 | 178.7K | $19,615 | +1.93% |
| Q3 2022 | 177.3K | $17M | +1.87% |
| Q2 2022 | 178.0K | $19M | +1.96% |
| Q1 2022 | 177.7K | $21M | +1.85% |
| Q4 2021 | 175.0K | $25M | +2.08% |
| Q3 2021 | 177.7K | $21M | +1.94% |
| Q2 2021 | 181.1K | $21M | +1.92% |
| Q1 2021 | 179.8K | $22M | +2.10% |
| Q4 2020 | 183.1K | $20M | +2.06% |
| Q3 2020 | 182.3K | $20M | +2.28% |
| Q2 2020 | 183.8K | $17M | +2.08% |
| Q1 2020 | 182.9K | $14M | +2.11% |
| Q4 2019 | 181.6K | $16M | +1.84% |
| Q3 2019 | 170.7K | $14M | +1.86% |
| Q2 2019 | 169.9K | $14M | +1.91% |
| Q1 2019 | 169.2K | $14M | +1.90% |
| Q4 2018 | 170.7K | $12M | +1.93% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kanawha Capital Management LLC’s full portfolio or all institutional holders of ABT.